News & Publications

News & Updates

View All

News 06.27.2025

National Coalition of HIV, LGBTQ+ and Health Advocates Applauds Court Decision Upholding Law that Ensures Access to PrEP and other Healthcare Preventive Services

In response to the Supreme Court decision on the Braidwood case today, June 27, a national coalition released the following statement from the Executive Directors of Lambda Legal, PrEP4All, the Center for Health Law and Policy Innovation, the Center for HIV Law and Policy, and Equality Federation: (Washington, DC – June 27) This Pride Month, […]

News 06.25.2025

A Statement on the Upcoming Braidwood Ruling from the Executive Directors of Lambda Legal, PrEP4All, the Center for Health Law and Policy Innovation, the Center for HIV Law and Policy, and the Equality Federation

This Pride Month, we are inundated by threats to the LGBTQ community—from book bans to attacks on gender-affirming care. But one case now before the Supreme Court stands out in its potential to inflict devastating harm far beyond our community. Kennedy v. Braidwood is not just an attack on HIV prevention or LGBTQ people—it’s a […]

Uncategorized 06.18.2025

STATEMENT: PrEP4All Statement on FDA Approval of Lenacapavir as PrEP

The long-anticipated approval of lenacapavir as a once every six-month injectable option for PrEP is a welcome development in the fight to end HIV as an epidemic. It is also a testament to the value and power of American taxpayer investment in the research at the National Institutes of Health that set the stage for […]

Our Publications

View All

Report 10.29.2024

The Path Forward for a National PrEP Program: Policy and Implementation Priorities

For media inquiries, contact Michael Chancley, Communications and Mobilization Manager, at [email protected]. Download: The Path Forward for a National PrEP Program – October 2024 Download One Page Summary of Report This year, PrEP4All convened over 50 PrEP users, providers, community leaders, health department representatives, and researchers from around the country to discuss best practices for […]

Report 09.12.2024

HIV Activism and US Biosecurity: An After-Action Report on the 2022 Global Mpox Crisis

Download Here. In September 2024, PrEP4All released “HIV Activism and US Biosecurity: An After-Action Report on the 2022 Global Mpox Crisis.” Funded by amfAR and based on in-depth interviews, a national survey and PrEP4All’s experience in collaboratively activating a community response, this report provides a detailed analysis of how HIV activists and frontline providers played […]

News 08.26.2024

A New Drug Could Change The HIV Prevention Landscape, But Only With A Fair Price Tag

This op-ed, written by PrEP4All Executive Director, Jeremiah Johnson, and Amy Killelea, Consultant, appeared in Health Affairs on August 26, 2024. In June, Gilead Sciences announced impressive early results from its PURPOSE 1 trial, which showed 100 percent efficacy of lenacapavir in preventing new HIV infections among cisgender women in Sub-Saharan Africa. Lenacapavir is being […]